Report cover image

United States Market for In Vitro Diagnostic Tests (Molecular Assays, Microbiology, Histology, Chemistry, Hematology, Blood Banking, POC and Other Tests)

Publisher Kalorama Information
Published Jun 27, 2016
Length 210 Pages
SKU # KLI15035998

Description

United States Market for In Vitro Diagnostic Tests

United States Market for In Vitro Diagnostic Tests takes a considered look at the U.S. in vitro diagnostics (IVD) market and examines what current market trends mean for diagnostic manufacturers and investors. This report includes important tools for business planners. Included are market size estimates and forecasts for the following U.S. IVD segments:
  • Clinical Chemistry Market (2015/2020)
  • Identification and Antibiotic Susceptibility Testing (ID/AST) Microbiology (Traditional) Market – Automated ID/AST, Manual/Semi‐Auto ID/AST, Blood Culture, Chromogenic Media, Rapid Micro (2015/2020)
  • Molecular Microbiology / Virology Market – HAIs/BSIs, HIV, Hepatitis, CT/NG, HPV, Respiratory, Mycobacteria/TB, Other (2015/2020)
  • Point-of-Care (POC) Diagnostics Markets – Professional (Drugs of Abuse, Infectious Disease, Pregnancy, Glucose, HbA1c, Lipids, Cardiac Markers, FOB, Critical Care, Coagulation, Hematology, Other), OTC Diabetes, OTC Other (2015/2020)
  • Immunoassays Market – Non Infectious (Cardiac Markers, Tumor Markers, HbA1c, Autoimmune, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic Drugs, Drugs of Abuse, Vitamin D) (2015/2020)
  • Immunoassays Market – Infectious (Hepatitis, HIV, STDs, ToRCH, Respiratory, HAIs/Sepsis, Parasitology, Mycology, Others) (2015/2020)
  • Urinalysis Lab Diagnostics Market (2015/2020)
  • Molecular Diagnostics Market (2015/2020)
  • Coagulation Diagnostics Market (2015/2020)
  • Histology and Cytology Diagnostics Market (2015/2020)
  • Hematology Diagnostics Market (2015/2020)
  • Blood Testing and Typing Diagnostics Market (2015/2020)
  • Clinical Flow Cytometry Market (2015/2020)
The United States represents the world’s largest in vitro diagnostics (IVD) market, projected to outpace other IVD markets in the developed world such as Western Europe and Japan. The report discusses market factors and trends, including:
  • continued expansion of the insured population under the ACA and increased healthcare utilization baselines;
  • demographic aging that increases demand for clinical testing paid for through the country’s leading vehicle for lab payments (Medicare);
  • relatively optimistic macroeconomic indicators vis-à-vis the domestic outlook five years ago or other developed markets in the world;
  • continued product innovation and industry responsiveness to clients’ needs in the world’s largest IVD market.
The report tracks developments, both challenging and positive, in the United States IVD market. Conclusions about the market are made concerning issues such as distribution of market share in IVD market segments, future U.S. IVD market growth, anticipated market obstacles, the growth of the molecular diagnostics market, and core lab IVD market growth.

United States Market for In Vitro Diagnostic Tests profiles in-depth the top tier U.S. IVD market participants. The total combined IVD sales of these top tier companies are estimated by Kalorama to represent nearly 70% of the total U.S. IVD market. The report ranks these firms and notes the IVD strengths of each. Companies discussed include:
  • Danaher Corporation
  • Roche Diagnostics
  • Siemens Healthcare Diagnostics

Table of Contents

210 Pages
    • Introduction
    • Market Metrics – Utilization
    • Market Metrics – Aging
    • Market Metrics – Disease
    • Market Metrics – U.S. Total Health and Clinical Lab Expenditures and Payers
    • Market Metrics – U.S. Clinical Testing by Channel
    • Impacts of the Affordable Care Act
    • Impacts of PAMA and LDT Reform
    • U.S. IVD Market
    • Top Tier U.S. IVD Market Participants and Rankings
    • Conclusions
    • The United States and In Vitro Diagnostics
    • U.S. Patient Population
    • Health Insurance in the United States and the Affordable Care Act
    • Clinical Testing under Medicare – Reimbursement Cuts and Market Based Pricing
    • Molecular Diagnostics and Medicare Policy
    • Laboratory DevelopedTests (LDTs) InvigorateMarket, Challenge Regulators
    • U.S. Healthcare Infrastructure and Testing Channels
    • Conclusions
    • Clinical Chemistry
    • Microbiology and Virology – ID/AST and Molecular
    • Point of Care Testing
    • Immunoassays
    • Urinalysis
    • Molecular Diagnostics
    • Coagulation
    • Histology
    • Hematology
    • Blood Testing and Typing
    • Flow Cytometry
    • Total U.S. IVD Market
    • Abbott Diagnostics
    • Alere
    • Beckman Coulter (Danaher)
    • Becton, Dickinson and Company (BD)
    • bioMérieux
    • Bio Rad Laboratories
    • Cepheid
    • Danaher Corporation
    • Hologic
    • Johnson & Johnson (Incl. Janssen Diagnostics)
    • Ortho Clinical Diagnostics
    • QIAGEN
    • Roche Diagnostics
    • Siemens Healthcare Diagnostics
    • Sysmex Corporation
    • Thermo Fisher Scientific

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us